Table 3. Contributors to the Global Drug Facility (including donations of cash and contributions in-kind), 2001–2006.
| Contributor | Year and amounta |
Total | |||||
|---|---|---|---|---|---|---|---|
| 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | ||
| Canadian International Development Agency | 9 944 | 3 723 | 8 530 | 11 347 | 20 643 | 22 862 | 77 049 |
| Government of Japan | 46 | 46 | |||||
| Government of Norway | 748 | 810 | 743 | 899 | 3 200 | ||
| Government of the Netherlands | 4 041 | 1 959 | 2 587 | 194 | 8 781 | ||
| Harvard Medical School | 130 | 130 | |||||
| Management Sciences for Health (contributions in-kind)b | 137 | 188 | 188 | 188 | 141 | 842 | |
| Novartis Foundation (contributions in-kind) | 2 605 | 3 226 | 5 831 | ||||
| Open Society Institute | 250 | 250 | |||||
| Procter & Gamble (contributions in-kind) | 25 | 25 | |||||
| Research Institute of Tuberculosis, Japan (contributions in-kind) | 21 | 21 | |||||
| UNITAIDc | 5 665 | 5 665 | |||||
| United Kingdom Department for International Development | 595 | 11 962 | 12 557 | ||||
| United States Agency for International Development | 1 250 | 2 000 | 3 000 | 3 000 | 4 700 | 5 000 | 18 950 |
| World Bank | 250 | 250 | 500 | ||||
| Total | 15 235 | 8 091 | 16 349 | 15 539 | 28 879 | 49 755 | 133 847 |
a Amounts are given in thousands of US$. b Examples of in-kind donations include contributions of staff time for consultancies and contributions of anti-TB drugs. c Funds from UNITAID for paediatric anti-TB drugs were agreed upon in 2006 but disbursed in 2007.